FDA
-
-
-
-
-
-
-
Delcath Systems Reports First Quarter 2026 Results and Business Highlights
-
-
-
-
-
-
-
Delcath Systems reports CHOPIN trial results published in The Lancet Oncology
-
-
-
-
-
-
-
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma
-
-
-
-
-
-
-
Delcath Systems reports Q3 revenue of $20.5 million, raises 2025 guidance
-
-
-
-
-
-
-
Delcath Systems to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Delcath Systems (DCTH) Issues Full Year 2025 Guidance
-
325,894 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

